30 January 2015, 10:00 am
AbbVie's investigational HCV protease inhibitor ABT-493 and NS5A inhibitor ABT-530 demonstrated good antiviral activity in patients with genotype 1 chronic hepatitis C in a three-day monotherapy study, as well as potent and synergistic activity against multiple HCV genotypes in laboratory replicon studies, according to presentations at the American Association for the Study of Liver Diseases

29 January 2015, 9:10 am
The idea that AIDS was created as part of a government-led conspiracy to decimate the African American population remains salient to a significant minority of black people, according to qualitative research published in the January edition of the American Journal of Public Health. The researcher argues that such rumours and narratives are the product of

28 January 2015, 8:40 am
People living with HIV who smoke have an almost three-fold greater risk of heart attack than HIV-negative smokers, according to Danish data published online ahead of print in Clinical Infectious Diseases. The study suggests that smoking drives the larger number of heart attacks observed in people living with HIV in resource-rich settings, with other factors

22 January 2015, 11:30 pm
A French study that looked at the total amount of time since infection that people with HIV have spent with a detectable viral load has found that, contrary to some researchers’ expectations, starting therapy immediately after infection and then interrupting it conferred no advantage compared to deferring treatment until CD4 counts fell below

21 January 2015, 11:10 am
Many people living with HIV in England have a limited understanding of the law which leaves them either at risk of prosecution for HIV transmission or with an overestimation of their legal obligations, according to a small qualitative study published online ahead of print in the Journal of Family Planning and Reproductive Health

1 2

    • No upcoming events
  • View All Add your news